Skip to content

Understanding the role of Homeopathy in cases of chronic ear infection.

Understanding the influence of miasm in cases of chronic otitis media using - COMOT-15 - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095260
Enrollment
50
Registered
2025-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H663- Other chronic suppurative otitis media

Interventions

Intervention1: Individualised Homoeopathic Medicine: Each patient will receive individualized homoeopathic medicines selected on the basis of totality of symptoms and predominant miasmatic background

Sponsors

Dr. Shilpaben Vaghela
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients above age of 14 years and all genders (including male, female and gender diverse individuals) are eligible for the study. 2.Patients with recurrent and chronic otitis media are eligible for the study. 3.Patients who are willing and are able to comply with the study protocol, including taking homoeopathic treatment, attending follow-up assessments are eligible for the study. 4.Patients who would give their written informed consent are eligible for the study.

Exclusion criteria

Exclusion criteria: 1.Patients having otitis media requiring only surgical intervention will be excluded. 2.Patients below age of 14 years will be excluded. 3.Patients with significant cognitive impairments will be excluded. 4.Patients who are unable or unwilling to comply with the study protocol, such as adhering to treatment regimen and attending follow-up visits will be excluded.

Design outcomes

Primary

MeasureTime frame
Reduction in COMOT-15 total score (ear symptoms, hearing function, mental health, and overall QoL) from baseline to end of treatment.Timepoint: Reduction in COMOT-15 total score (ear symptoms, hearing function, mental health, and overall QoL) from baseline to end of treatment.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Shilpaben Pareshbhai Vaghela

Anand Homeopathic Medical College and Research Institute, Anand.

dr.rupalmehta9@gmail.com7600020410

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026